老年慢性病患者合作药物治疗管理模式的探索

doi:10.5246/jcps.2022.11.073

摘要/Abstract

摘要：

我国正快速进入老龄化社会, 多病共存、多重用药、机体功能下降是老年患者面临的严峻问题。实施慢性病的综合防控, 加强老年常见病、慢性病的健康指导和综合干预, 强化老年人的健康管理等措施势在必行。合作药物治疗管理(Collaborative drug therapy management, CDTM)是新医改形势下药学服务实践过程中应运而生的一种药物治疗管理模式, 旨在扩大药师在医疗团队中的作用, 提升医院医疗服务质量。CDTM虽然在老年慢性病管理中已取得初步成效, 但由于医院配套设施、管理模式和药师能力的差异, 在我国的推广受到了限制。本文通过对老年慢性病合作药物治疗管理模式的探索, 为CDTM服务的进一步推广提供参考, 同时为药师价值的展现, 真实药学服务的实现奠定良好基础。

关键词: 老年患者, 慢性病, 合作药物治疗管理, 药学服务

Abstract:

As China is accelerating into an aging society, the coexistence of multiple diseases, multiple drugs, and the decline of body function are serious problems faced by elderly patients. Therefore, it is imperative to carry out the comprehensive prevention and control of chronic diseases, strengthen the health guidance and comprehensive intervention of common and chronic diseases of the elderly, and strengthen the health management of elderly patients. Collaborative drug therapy management (CDTM) is a drug treatment management mode that emerged in pharmaceutical services under the situation of new medical reform, aiming to expand the role of pharmacists in the medical team and improve the quality of hospital medical service. Although CDTM has shown some favorable effects in managing chronic diseases in the elderly population, the popularization of CDTM in China is limited by the differences in supporting facilities, management mode, and pharmacist's abilities in hospitals. By exploring the CDTM mode for elderly patients with chronic diseases, we provided a reference for further promoting the CDTM services and laid a good foundation for displaying pharmacist value and the realization of real pharmaceutical care.

Key words: Elderly patients, Chronic diseases, CDTM, Pharmaceutical services

Supporting:

冯书云, 陈朋举, 王宁, 赵博, 卢奕帆, 张永恒. 老年慢性病患者合作药物治疗管理模式的探索[J]. 中国药学(英文版), 2022, 31(11): 866-876.

Shuyun Feng, Pengju Chen, Ning Wang, Bo Zhao, Yifan Lu, Yongheng Zhang. Exploration of collaborative drug therapy management mode for elderly patients with chronic diseases[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(11): 866-876.

参考文献 53

[1]	Department of planning, development and informatization of China government network. The healthy China action (2019-2030) [EB/OL]. [2019-07-15]. http://www.nhc.gov.cn/ guihuaxxs/s3585u/201907/e9275fb95d5b4295be8308415 d4cd1b2.shtml.
[2]	Liang, C.; Mao, X.H.; Niu, H.T.; Huang, K.; Dong, F.; Chen, Y.H.; Huang, K.W.; Zhan, Q.Y.; Huang, Y.; Zhang, Y.W.; Yang, T.; Wang, C. Characteristics, management and In-hospital clinical outcomes among inpatients with acute exacerbation of chronic obstructive pulmonary disease in China: results from the phase I data of ACURE study. Int. J. Chron. Obstruct. Pulmon. Dis. 2021, 16, 451–465.
[3]	Cohen, H. Pharmacists and collaborative drug therapy management in New York State. J. Pharm. Pract. 2011, 24, 582–583.
[4]	The Central Committee of the Communist Party of China, State council. Outline of "Healthy China 2030" Plan [S]. (2016/10/25) [2022/04/10]. http://www.gov.cn/zhengce/ 2016/10/25/content_5124174.htm.
[5]	Feng, S.Y.; Guo, J.H.; Lu, Y.Z. Pharmaceutical practice and value of pharmacists under the new medical reform situation. J. Chin. Pharm. Sci. 2018, 27, 630–636.
[6]	Xie, X.H.; Xiang, L. A study of the impact of pharmaceutical care on medication compliance in asthmatic children. J. Chin. Pharm. Sci. 2010, 19, 130–135.
[7]	Xie, C.x.; Wang, W.; Huang, G.; Jin, X.; Wang, C.l.; Yin, D. Pharmacist-Led Interventions to Reduce Inappropriate Drug Use in the Orthopaedics Department in China. J. Chin. Pharm. Sci. 2020, 29, 375–382.
[8]	Rahayu, S.A.; Widianto, S.; Defi, I.R.; Abdulah, R. Role of pharmacists in the interprofessional care team for patients with chronic diseases. J. Multidiscip. Healthc. 2021, 14, 1701–1710.
[9]	Pellegrino, A.N.; Martin, M.T.; Tilton, J.J.; Touchette, D.R. Medication therapy management services: definitions and outcomes. Drugs. 2009, 69, 393–406.
[10]	Schommer, J.C.; Planas, L.G.; Johnson, K.A.; Doucette, W.R. Pharmacist-provided medication therapy management (part 1): provider perspectives in 2007. J. Am. Pharm. Assoc. 2008, 48, 354–363.
[11]	Schommer, J.C.; Planas, L.G.; Johnson, K.A.; Doucette, W.R. Pharmacist-provided medication therapy management (part 2): payer perspectives in 2007. J. Am. Pharm. Assoc. 2008, 48, 478–486.
[12]	Barnett, M.J.; Frank, J.; Wehring, H.; Newland, B.; VonMuenster, S.; Kumbera, P.; Halterman, T.; Perry, P.J. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J. Manag. Care Pharm. 2009, 15, 18–31.
[13]	Moczygemba, L.R.; Barner, J.C.; Brown, C.M.; Lawson, K.A.; Gabrillo, E.R.; Godley, P.; Johnsrud, M. Patient satisfaction with a pharmacist-provided telephone medication therapy management program. Res. Soc. Adm. Pharm. 2010, 6, 143–154.
[14]	Moczygemba, L.R.; Barner, J.C.; Gabrillo, E.R. Outcomes of a Medicare Part D telephone medication therapy management program. J. Am. Pharm. Assoc. 2012, 52, e144–e152.
[15]	Liu, Q.Y.; Yan, S.Y. Research Situation of Pharmacist-Guided Medication Therapy Management in Elderly Patients with Chronic Diseases. Pract. Pharm. And. Clin. Remed. 2020, 23, 1029–1037.
[16]	Kim, A.J.; Lee, H.; Shin, E.J.; Cho, E.J.; Cho, Y.S.; Lee, H.; Lee, J.Y. Pharmacist-led collaborative medication management for the elderly with chronic kidney disease and polypharmacy. Int. J. Environ. Res. Public Health. 2021, 18, 4370.
[17]	Hammond, R.W.; Schwartz, A.H.; Campbell, M.J.; Remington, T.L.; Chuck, S.; Blair, M.M.; Vassey, A.M.; Rospond, R.M.; Herner, S.J.; Webb, C.E.; Pharmacy, A.C.O.C. Collaborative drug therapy management by pharmacists: 2003. Pharmacotherapy. 2003, 23, 1210–1225.
[18]	Twigg, G.; Motsko, J.; Thomas, J.; David, T. Pharmacist-managed diabetes center interventions ensure quality and safety in elderly patients. Consult. Pharm. 2017, 32, 299–310.
[19]	Marr, T.D.; Pinelli, N.R.; Jarmul, J.A.; Waldron, K.M.; Eckel, S.F.; Cicci, J.D.; Bates, J.S.; Amerine, L.B. Continuous care provided through comprehensive medication management in an acute care practice model. Ann. Pharmacother. 2018, 52, 314–324.
[20]	Henrich, N.; Tsao, N.; Gastonguay, L.; Lynd, L.; Marra, C.A. BC Medication Management Project: perspectives of pharmacists, patients and physicians. Can. Pharm. J. (Ott). 2015, 148, 90–100.
[21]	Chen, T.F. Pharmacist-led home medicines review and residential medication management review: the Australian model. Drugs Aging. 2016, 33, 199–204.
[22]	Patel, A.; Praveen, D.; Maharani, A.; Oceandy, D.; Pilard, Q.; Kohli, M.P.S.; Sujarwoto, S.; Tampubolon, G. Association of multifaceted mobile technology-enabled primary care intervention with cardiovascular disease risk management in rural Indonesia. JAMA Cardiol. 2019, 4, 978–986.
[23]	Berenguer, B.; La Casa, C.; de la Matta, M.J.; Martín-Calero, M.J. Pharmaceutical care: past, present and future. Curr. Pharm. Des. 2004, 10, 3931–3946.
[24]	Almodóvar, A.S.; Nahata, M.C. Associations between chronic disease, polypharmacy, and medication-related problems among medicare beneficiaries. J. Manag. Care Specialty Pharm. 2019, 25, 573–577.
[25]	Burns, A. Medication therapy management in community pharmacy practice: core elements of an MTM service (version 1.0). J. Am. Pharm. Assoc. 2005, 45, 573–579.
[26]	Burns, A. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J. Am. Pharm. Assoc. 2008, 48, 341–353.
[27]	Carter, B.L.; Bergus, G.R.; Dawson, J.D.; Farris, K.B.; Doucette, W.R.; Chrischilles, E.A.; Hartz, A.J. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control. J. Clin. Hypertens. 2008, 10, 260–271.
[28]	Tilton, J.J.; Edakkunnathu, M.G.; Moran, K.M.; Markel Vaysman, A.; DaPisa, J.L.; Goen, B.M.; Touchette, D.R. Impact of a medication therapy management clinic on glycosylated hemoglobin, blood pressure, and resource utilization. Ann. Pharmacother. 2019, 53, 13–20.
[29]	Fox, D.; Ried, L.D.; Klein, G.E.; Myers, W.; Foli, K. A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes. J. Am. Pharm. Assoc. 2009, 49, 192–199.
[30]	Alosaimy, S.; Vaidya, A.; Day, K.; Stern, G. Effect of a pharmacist-driven medication management intervention among older adults in an inpatient setting. Drugs Aging. 2019, 36, 371–378.
[31]	Caffiero, N.; Delate, T.; Ehizuelen, M.D.; Vogel, K. Effectiveness of a clinical pharmacist medication therapy management program in discontinuation of drugs to avoid in the elderly. J. Manag. Care Spec. Pharm. 2017, 23, 525–531.
[32]	Tate, M.L.; Hopper, S.; Bergeron, S.P. Clinical and economic benefits of pharmacist involvement in a community hospital-affiliated patient-centered medical home. J. Manag. Care Specialty Pharm. 2018, 24, 160–164.
[33]	Pellegrin, K.L.; Krenk, L.; Oakes, S.J.; Ciarleglio, A.; Lynn, J.; McInnis, T.; Bairos, A.W.; Gomez, L.; McCrary, M.B.; Hanlon, A.L.; Miyamura, J. Reductions in medication-related hospitalizations in older adults with medication management by hospital and community pharmacists: a quasi-experimental study. J. Am. Geriatr. Soc. 2017, 65, 212–219.
[34]	Zhang, J.Y.; Qin, D.; Huang, B.Y.; Zheng, S.; Xu, H.Z.; Yu, Q.; Zhang, H.; Liao, Q.Q. Research advances for medication therapy management. Chin. J. Hosp. Pharm. 2021, 41, 1271–1275.
[35]	Yang, Y.; Gao, H.; Tong, R.S. Running study of collaborative drug therapy management model in respiratory therapy profession. Drug Eval. 2010, 7, 15–18.
[36]	Yu, Z.C.; Liu, G.L. Drug management service: a new opportunity in pharmaceutical care practice. Chin. J. Clin. Pharm. 2015, 24, 313–317.
[37]	Gao, J.; Hou, Y.L. The first batch of drug treatment management pharmacists in China was born in Beijing, and 60 pharmacists were also certified by American Pharmacists Association. Cap. Food Med. 2016, 23, 26.
[38]	Bian, J.B. Brief introduction of the pharmacist certificate training program of American Drug Treatment Management (MTM) launched by Guangdong Pharmaceutical Society. Pharm. Today. 2016, 26, 638.
[39]	Yan, S.Y. Expert consensus on medication therapy management training and practice in China. Clin. Med. J. 2020, 18, 21–25.
[40]	Alhossan, A.; Alazba, A. Barriers interfering with establishment of Collaborative Drug Therapy Management (CDTM) agreements between clinical pharmacists and physicians. Saudi Pharm. J. 2019, 27, 713–716.
[41]	Tewksbury, A.; Bozymski, K.M.; Ruekert, L.; Lum, C.; Cunningham, E.; Covington, F. Development of collaborative drug therapy management and clinical pharmacy services in an outpatient psychiatric clinic. J. Pharm. Pract. 2018, 31, 272–278.
[42]	Leung, H.Y.; Saini, B.; Ritchie, H.E. Medications and pregnancy: the role of community pharmacists - A descriptive study. PLoS One. 2018, 13, e0195101.
[43]	Gu, H.Y.; Li, D.; Yuan, R.L.; Bian, B.S.; Yan, S.Y.; Kong, F.C.; Sun, L.L.; Jiang, D.C.; Hou, Y.L.; Liu, J.T.; Yan, B. Teaching exploration and practice on medication therapy management service. Clin. Med. J. 2018, 16, 10–14.
[44]	Cranor, C.W.; Bunting, B.A.; Christensen, D.B. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J. Am. Pharm. Assoc. 2003, 43, 173–184.
[45]	Bunting, B.A.; Cranor, C.W. The Asheville project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J. Am. Pharm. Assoc. 2006, 46, 133–147.
[46]	Bunting, B.A.; Smith, B.H.; Sutherland, S.E. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J. Am. Pharm. Assoc. 2008, 48, 23–31.
[47]	Theising, K.M.; Fritschle, T.L.; Scholfield, A.M.; Hicks, E.L.; Schymik, M.L. Implementation and clinical outcomes of an employer-sponsored, pharmacist-provided medication therapy management program. Pharmacother. J. Hum. Pharmacol. Drug Ther. 2015, 35, e159–e163.
[48]	Unger, T.; Borghi, C.; Charchar, F.; Khan, N.A.; Poulter, N.R.; Prabhakaran, D.; Ramirez, A.; Schlaich, M.; Stergiou, G.S.; Tomaszewski, M.; Wainford, R.D.; Williams, B.; Schutte, A.E. 2020 International Society of Hypertension global hypertension practice guidelines. J. Hypertens. 2020, 38, 982–1004.
[49]	Benetos, A.; Petrovic, M.; Strandberg, T. Hypertension management in older and frail older patients. Circ. Res. 2019, 124, 1045–1060.
[50]	Stergiou, G.S.; Palatini, P.; Parati, G.; O'Brien, E.; Januszewicz, A.; Lurbe, E.; Persu, A.; Mancia, G.; Kreutz, R.; European Society of Hypertension Council and the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J. Hypertens. 2021, 39, 1293–1302.
[51]	Thompson, K.; Kulkarni, J.; Sergejew, A.A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr. Res. 2000, 42, 241–247.
[52]	Renfro, C.P.; Ferreri, S.; Barber, T.G.; Foley, S. Development of a communication strategy to increase interprofessional collaboration in the outpatient setting. Pharmacy (Basel) 2018, 6, 4.
[53]	Zhao, L.; Zhong, L.H.; Cui, J.; Liu, M.Y.J.; Xu, L.; Wang, C.Y. Exploratory Research on Chronic Disease Medical Data Platform Based on Medication Therapy Management. J. Pharm. Res. 2020, 39, 115–117.